Insider Transactions in Q1 2022 at Yield10 Bioscience, Inc. (YTEN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Anthony J Sinskey Director |
BUY
Open market or private purchase
|
Direct |
1,000
+8.12%
|
$6,000
$6.23 P/Share
|
|
Mar 01
2022
|
Kristi Snell VP Research and CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-3.6%
|
$1,672
$4.25 P/Share
|
|
Mar 01
2022
|
Lynne H Brum VP Planning and Communications |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-3.46%
|
$1,464
$4.25 P/Share
|
|
Mar 01
2022
|
Oliver P Peoples President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,827
-3.53%
|
$7,308
$4.25 P/Share
|
|
Mar 01
2022
|
Charles B Haaser VP Finance and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
341
-2.74%
|
$1,364
$4.25 P/Share
|
|
Feb 10
2022
|
Oliver P Peoples President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,023
+41.06%
|
$108,069
$3.83 P/Share
|
|
Feb 10
2022
|
Lynne H Brum VP Planning and Communications |
BUY
Grant, award, or other acquisition
|
Direct |
5,891
+35.76%
|
$17,673
$3.83 P/Share
|
|
Feb 10
2022
|
Charles B Haaser VP Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
5,603
+31.05%
|
$16,809
$3.83 P/Share
|
|
Feb 10
2022
|
Kristi Snell VP Research and CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,733
+36.72%
|
$20,199
$3.83 P/Share
|